Other News

Bendit Technologies Announces Senior Management Appointments

Richard Cappetta has been appointed Chairman of the Board and Yossi Mazel will be the new CEO TEL AVIV, Israel, June 23, 2020 /PRNewswire/ — Bendit Technologies, an industry leader in the development of steerable microcatheters, announced today that Richard Cappetta has been appointed as its Chairman of the Board. Together with this appointment, it was announced that Yossi […]

Philips receives FDA premarket approval for its HeartStart FR3 and HeartStart FRx automated external defibrillators

Amsterdam, the Netherlands and Cambridge, MA – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that the Center for Devices and Radiological Health (CDRH) of the U.S. Food and Drug Administration (FDA) has granted premarket approval (PMA) for the company’s HeartStart FR3 [1] and HeartStart FRx [2] […]

TARA Biosystems Announces $10 Million Series A2 Financing to Expand its Cardiac Disease Drug Discovery and Development Capabilities

NEW YORK–(BUSINESS WIRE)–TARA Biosystems, Inc., a company generating in vitro human biology to increase the success of cardiac disease drug discovery and development, today announced a $10 million Series A2 financing. This financing will be used to scale TARA’s cardiac tissue engineering platform technology and advance its drug discovery programs. New investors […]

Medtronic Evolut TAVI System Receives Expanded Indication in Europe to Treat Severe Aortic Stenosis Patients at Low Risk for Surgical Mortality

he Evolut TAVI Platform Receives New Indication for Patients with Bicuspid Aortic Valves at Extreme, High or Intermediate Risk of Surgical Mortality DUBLIN, June 22, 2020 (GLOBE NEWSWIRE) — Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced CE (Conformité Européenne) mark and European launch of the Evolut™ Transcatheter […]

MyoKardia Announces Positive Data from Phase 2a Clinical Trial of Danicamtiv Presented at ESC’s HFA Discoveries with Simultaneous Publication in European Journal of Heart Failure

Danicamtiv was Well Tolerated; Demonstrated Improvements in Cardiac Contractility and Preserved Diastolic Function in Patients with Stable Heart Failure with Reduced Ejection Fraction New Observations Show Improvements in Left Atrial Volume and Function, Key Prognostic Indicators of Atrial Fibrillation Additional Nonclinical Studies Also Presented Demonstrating Danicamtiv’s Differentiated Mechanistic Profile Including Direct […]

Resverlogix Reaches Agreement With FDA for Key Aspects of Apabetalone Registration Enabling Study

CALGARY, Alberta, June 22, 2020 (GLOBE NEWSWIRE) — Resverlogix Corp. (“Resverlogix”) (TSX:RVX) is pleased to announce that the U.S. Food & Drug Administration (FDA) has accepted its BETonMACE2 clinical plan as a registration enabling study with positive implications for Resverlogix and its ongoing partnership discussions. Key written development points from […]

Paragonix Technologies Announces Appointment of Alexander K. Arrow, MD, CFA to the Board of Directors

Paragonix expands Boards to support rapid commercial growth in the heart transplant market CAMBRIDGE, Mass.–(BUSINESS WIRE)–Paragonix Technologies, Inc. a commercial stage company and leader in organ preservation and transport technology, today announced that Alexander K. Arrow, MD, CFA has joined its Board of Directors. Dr. Arrow is a medical technology […]